5. Surgery : local treatment, may be disfiguring but if the tumor can be
removed it is quite successful
Radiation: regional treatment, may have less side effects then surgery,
successful if the cancer is radio-sensitive
Chemotherapy: widespread, treats the whole body, may have
significant side effects, success depends completely on whether the
cancer is sensitive to the available drugs
Basic Cancer Treatments
6. Combined Modality Therapy in the
Treatment of Pediatric Rhabdomyosarcoma
Treatment 5 Year Survival
Surgery 10 – 20%
Surgery plus PostOp Radiation 40 – 50%
Surgery, Radiation then Chemotherapy 80 – 90%
7. •Need a cancer that is sensitive to radiation (or at
least more sensitive to radiation than the normal
structures around it) e.g. Hodgkin’s Lymphoma
•Need to be able to hit the target.
Need for Radiation to be Effective
8. Thomas Hodgkin in 1832 Boy with Hodgkin’s in 1920
Until the 1960s, among patients with an advanced stage of Hodgkin's
disease the median survival was 2 years, and only 5% of patients lived
beyond 4 years.
Currently it is curable in 85 to 95% of cases, depending on its stage
9. Survival I also very high
with chemotherapy alone
so radiation may not even
be necessary in many
patients
Shift away from maximum
treatment to aiming for the
least treatment necessary
to avoid long term
complications
15. Three ways to get radiation to
hit the target
1.External Beam: radiation outside the body
2.Brachytherapy: ‘close therapy’ insert seeds,
wires, needle, balloons into the body
3.Isotope therapy: infuse radioactive particles into
the blood supply that will then find it’s way to the
cancer
18. Survival after lumpectomy and mastectomy for early-stage invasive breast cancer
Cancer 2013;119:1402
Women under 50y Women 50y or older
Survival in Months Survival in Months
Lumpectomy + Radiation
Lumpectomy + Radiation
Mastectomy Mastectomy
Study of 112,154 women in California, all Stage I or II diagnosed between 1990-2004
23. Cure Rates with Radiation versus Surgery for Early-Stage Prostate
Cancer are the same
from the Cleveland Clinic.
Kupelian. JCO Aug 15 2002: 3376-3385
24. 10 Year Cure Rates for Patients with High-Risk
Prostate Cancer (PSA >20 or Gleason 8-10 or T3)
Treatment Number Cure Rate
Radical Prostatectomy 1,238 92%
Radiation plus Hormones 344 92%
Radiation alone 265 88%
Mayo Clinic Study (Boorjian Cancer 117;2883, 2011)
27. Isotopes in Use for Radiotherapy
Isotope Energy Half-life HVL
(mm lead)
Radium (Ra225) 0.83Mev 1626 y 16mm
Cesium (Cs 137) 0.662 30 y 6.5mm
Cobalt (Co 60) 1.25 5.26 y 11mm
Iridium (Ir 192) 0.397 73.8 d 6mm
Palladium (Pd 103) 0.020 17 d .013mm
Iodine (I 125) 0.028 59.6d .025
31. SIR-Spheres Y-90 resin microspheres for Liver Metastases
Normal liver cells are fed from the Portal Vein
32. SIR-Spheres Y-90 resin microspheres for Liver Metastases
The Hepatic Artery feeds the Cancer Cells
33. SIR-Spheres Y-90 resin microspheres for Liver Metastases
Insert the microspheres through the hepatic artery into the
vessels that feed the cancer
34. SIR-Spheres Y-90 resin microspheres for Liver Metastases
The microspheres get trapped in the capillary beds of the cancer and the radiation
kills only the cancer
47. Note that as of
February 2022 the
guidelines have
already been updated
twice and are 244
pages long
These are quite
complicated but note
there is a link to patient
friendly guidelines.
48. Best source for current cancer information is the NCCN (National Comprehensive Cancer Network)
https://www.nccn.org/ https://www.nccn.org/patientresources/patient-resources